Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Skin & Wound Healing

Effect of the combination of photobiomodulation therapy and the intralesional administration of corticoid in the preoperative and postoperative periods of keloid surgery: A randomized, controlled, double-blind trial protocol study

All data will be submitted to statistical analysis. Trial registration: This study is registered in ClinicalTrials.gov (ID: NCT04824612).

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

This is a protocol for a planned randomized, double-blind trial testing blue-light photobiomodulation combined with intralesional corticosteroid around keloid removal surgery. The authors describe comparing active treatment with a sham group and plan to assess scars with the Vancouver Scar Scale and related questionnaires over twelve months. No results are reported, so no conclusions about effectiveness can be drawn.

Who or what was studied
Patients undergoing keloid removal surgery; planned two groups of 29 each (58 total planned), not yet enrolled results reported.
Wavelengths
470 nm
Limits stated in the abstract
This is a trial protocol only, so no outcome data are reported and the planned findings are unknown.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Patients Will Answer Two Questionnaires

one for the assessment of quality of life (Qualifibro-UNIFESP) and one for the assessment of satisfaction with the scar (PSAQ). The team of five plastic surgeons will answer the Vancouver Scar Scale (VSS). All questionnaires will be administered one, three, six, and twelve months postoperatively. The keloids will be molded in silicone prior to the onset of treatment and prior to excision to assess pre-treatment and post-treatment size. The same will be performed for the remaining scar at one, three, six, and twelve months postoperatively. The removed keloid will be submitted to histopathological analysis for the determination of the quantity of fibroblasts, the organization and distribution of collagen (picrosirius staining), and the genic expression of TGF-β (qPCR). All data will be submitted to statistical analysis.

Trial Registration

This study is registered in ClinicalTrials.gov (ID: NCT04824612).

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

Light parameters mentioned

Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.

Wavelength
470 nm
Power
400 mW
Total energy
4J

How to read a trial: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Photobiomodulation therapy, Light-emitting diode, Collagen, Sham, Trial registration, Wavelength. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies